Concepedia

Christopher D. Turner

CD

Statistics

Publications

53

Citations

6.3K

H-Index

29

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Ariadne Diagnostics (United States)

University of Michigan

Washington University in St. Louis

Christopher D. Turner is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1991–2021

53

Publications

53

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

, , +10

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, Hagop M. Kantarjian, Neil P. Shah et al. · New England Journal of Medicine · 2012 · 759 citations · Full text

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

Justin F. Gainor, Giuseppe Curigliano, Dong‐Wan Kim et al. · The Lancet Oncology · 2021 · 428 citations · Full text

Moyamoya following cranial irradiation for primary brain tumors in children

Nicole J. Ullrich, Richard L. Robertson, Daniel D. Kinnamon et al. · Neurology · 2007 · 331 citations

1–5 of 53